Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial | Zendy

Jesús Almendral | Zendy; Fernando Arribas | Zendy; Christian Wolpert | Zendy; Renato Pietro Ricci | Zendy; Pedro Adragão | Zendy; Erik Cobo | Zendy; Xavier Navarro | Zendy; Aurelio Quesada | Zendy

Open Access

Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial

Author(s) -

Jesús Almendral,

Fernando Arribas,

Christian Wolpert,

Renato Pietro Ricci,

Pedro Adragão,

Erik Cobo,

Xavier Navarro,

Aurelio Quesada

Publication year - 2008

Publication title -

ep europace

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.119

H-Index - 102

eISSN - 1532-2092

pISSN - 1099-5129

DOI - 10.1093/europace/eun072

Subject(s) - medicine , implantable cardioverter defibrillator , single chamber , cardiology , adverse effect , ejection fraction , clinical endpoint , randomized controlled trial , artificial cardiac pacemaker , heart failure

This randomized trial evaluated clinically significant adverse events (CSAEs), in patients implanted with dual-chamber (DC) vs. single-chamber (SC) implantable cardioverter defibrillator (ICD). DC-ICD had atrial tachyarrhythmia (AT) therapy capabilities. Strict programming recommendations were reinforced.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research